CELL GENESYS (NASDAQ:CEGE)

0.33

-0 (-0%)

CELL GENESYS (NASDAQ:CEGE) Delayed :
Previous Close	$0.33	52 Week High	$0.90
Open	$0.33	52 Week Low	$0.16
Day High	$0.33	P/E	N/A
Day Low	$0.33	EPS	$-0.39
Volume	796,581
More CEGE Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
BPAX	8	ELX	1
PTRY	1	BPAX	1
BRCM	1

View All Entities

Jun 30, 2009 08:09 AM BioSante (BPAX) and Cell Genesys (CEGE) Agree to Merge; Deal Valued at $38M
Apr 30, 2009 09:08 AM Cell Genesys (CEGE) Reports Q1 Loss of $0.10
Mar 9, 2009 04:07 PM Cell Genesys (CEGE) Tops Q4 EPS by 1c

Sep 30, 2009 04:21 PM BioSante Pharmaceuticals (BPAX) and Cell Genesys (CEGE) Announce Approval of Merger by BioSante Stockholders
Sep 23, 2009 08:02 AM BioSante Pharmaceuticals (BPAX) and Cell Genesys (CEGE) Announce Final Exchange Ratio for Merger
Jun 30, 2009 09:45 AM Notable Mergers and Acquisitions of the Day 6/30: BRCM/ELX, BPAX/CEGE, PTRY
Jun 30, 2009 08:09 AM BioSante (BPAX) and Cell Genesys (CEGE) Agree to Merge; Deal Valued at $38M
Jun 23, 2009 08:20 AM Cell Genesys (CEGE) Reports Tender Offer Results, Continues to Pursue Strategic Alternatives

Oct 14, 2009 01:34PM BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
Oct 14, 2009 01:17PM BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
Sep 30, 2009 04:15PM BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009
Sep 30, 2009 04:15PM BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009

Nov 16, 2009 02:38 AM Developments for Parkinson's Disease Ignite Investor Enthusiasm
Oct 21, 2009 05:09 AM Transformative Times for BioSante Pharmaceuticals
Sep 27, 2009 06:08 AM BioSante Pharma's LibiGel: Big Upside Potential
Sep 2, 2009 07:39 AM La Jolla Is Too Much of a Gamble Right Now
Jul 5, 2009 09:40 AM Dealmaking Sweeps the Biotech Sector

Scott Ferguson
on Jul 1, 2009
at 02:43 AM Merger or Fleece It appears that CEGE got all their ducks in order on June 23, 2009. We were told that the firm had approx 36 million in cash and that the OS was approx 109 million. Each common share would have a value of approx .33 cents per. One week later the BOD announces a merger with BPAX!!!! One week later!. It is a stock deal valued at 38 million in BPAX stock. What a joke...it appears that the only winners are a few left at the top . Is it true that Dr. SHERWIN will receive about 5 million USD dollars? WHY?. This is not a merger it is a take under. Cege was working on Cancer and Parkinson's.....why did we partner with a firm that has zero relevant data. The deal is very poor for CEGE Shareholders. The two firms have a lock up penalty of One million if this does not happen. Something is very wrong with this deal. Regards, Scott Ferguson
Article: BioSante (BPAX) and Cell Genesys (CEGE) Agree to Merge; Deal Valued at $38M
lighthouse905
on May 1, 2009
at 10:01 AM CEGC This stock is a winner..
Article: Cell Genesys (CEGE) Reports Q1 Loss of $0.10
Murray
on Apr 30, 2009
at 10:16 AM Buying volume of CEGE CEGE seems to be on the brink of closing down, In view of this, why is Leroy Kopp buying huge amounts of the stock?
Article: Cell Genesys (CEGE) Reports Q1 Loss of $0.10

RAND at Aug 15, 2009 02:59 PM CEGE CEGE IS GOING NO WERE BUT UP. $2.OO BY THE END OF SEPTEMBER.